ClinConnect ClinConnect Logo
Search / Trial NCT04282473

Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Feb 21, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

**Clinical Trial Summary:**

This clinical trial is looking at the long-term effects of using a special mesh (called the Parietex™ TCM Parietal Prosthesis) during a terminal colostomy surgery. A colostomy is a procedure where part of the bowel is brought out through the abdomen, often needed for patients with certain health conditions. The goal of this study is to see how many patients develop a parastomal hernia (a type of bulge that can occur around the stoma) five years after their surgery—comparing those who had the mesh placed with those who did not.

To be eligible for this trial, you must be part of a health insurance program and have had a colostomy for five years as part of the earlier GRECCAR 07 study. Participants will be closely monitored to assess their health and any complications related to the colostomy. This study is currently recruiting participants, and it's important to know that you cannot join if you are part of another study or if you are pregnant or breastfeeding. This research aims to improve the understanding of how mesh may help prevent hernias after colostomy surgery, which can help doctors make better treatment decisions in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The patient must be affiliated with a health insurance programme
  • Patient was included in the GRECCAR 07 cohort (PHRC National 2011; N° RCB: 2011-A01572-39 - ClinicalTrials.gov ID: NCT01380860)
  • Patient received colostomy 5 years ago
  • Exclusion Criteria:
  • The subject is participating in another category I interventional study, or is in a period of exclusion determined by a previous study
  • The subject signals opposition to participating in the study
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant or breastfeeding

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Rennes, , France

Lille, , France

Bordeaux, , France

Lyon, , France

Clichy, , France

Grenoble, , France

Nîmes, , France

Marseille, , France

Besançon, , France

Clermont Ferrand, , France

Marseille, , France

Montpellier, , France

Nantes, , France

Paris, , France

Rouen, , France

Toulouse, , France

Patients applied

0 patients applied

Trial Officials

Michel Prudhomme, MD

Principal Investigator

CHU Nimes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials